PCV56 COST-EFFECTIVENESS OF THE SUSTAINED-RELEASE PACLITAXEL-ELUTING ELUVIA STENT COMPARED TO THE PACLITAXEL-COATED ZILVER PTX STENT FOR ENDOVASCULAR TREATMENT OF PERIPHERAL ARTERY DISEASE: A GERMAN STATUTORY SICKNESS FUND PERSPECTIVE.
Abstract
Authors
C. Giretti W.A. Gray P. Elroy R.L. Akehurst S.L. Amorosi R. Griffiths S. Müller-Hülsbeck